US5215680A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for the production of medical-grade lipid-coated microbubbles, paramagnetic labeling of such microbubbles and therapeutic uses of microbubbles
Assignee: Cavitation-Control Technology Inc
•
Filing: 1990-07-10
•
Granted: 1993-06-01
•
Expires: 2010-07-10
Abstract
Abstract This invention relates to a large scale method for the production of medical grade lipid-coated microbubbles, to the paramagnetic labeling of such microbubbles and to therapeutic applications for the microbubbles. More particularly, the invention relates to a method of the production of medical grade, concentrated suspensions of stable, paramagnetically derivatized or underivatized microbubbles useful for ultrasonic and magnetic resonance imaging and also relates to therapeutic interventions such as selective tumor destruction.
Inventors
- 👤 Joseph S. D'Arrigo
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 04:56
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/48; A61K9/50; A61K9/5005; A61K9/5015; A61K41/00; A61K41/0047; A61K49/00; A61K49/06; A61K49/18; A61K49/1806; A61K49/1815; A61K49/22; A61K49/222; A61K49/223; Y; Y10; Y10T; Y10T436/00; Y10T436/24
Claims Analysis
Total Claims: 11
Claim 1
Independent Claim
292 words
A method for preparing an imaging about suitable for enhancement of ultrasonic imaging and magnetic resonance imaging comprising the steps of: A. obtaining a moderately hydrophobic neutral amino acid homopolymer or copolymer which is capable of readily incorporating into a lipid monolayer, and is labeled with a paramagnetic complex comprising a metal ion and organic chelating ligand; B. dissolving the labeled, hydrophobic polymer in a saline solution in an amount of about 10 mM; C. adding a surfactant mixture comprising: (a) a member selected from the group consisting of glycerol monoesters of saturated carboxylic acids containing from about 10 to about 18 carbon atoms and aliphatic alcohols containing from about 10 to about 18 carbon atoms; (b) a sterol-aromatic acid ester; (c) a member selected from the group consisting of sterols, terpenes, bile acids and alkali metal salts of bile acids; (d) a member selected from the group consisting of sterol esters of aliphatic acids containing from one to about 18 carbon atoms; sterol esters of sugar acids; esters of sugar acids and aliphatic alcohols containing from about 10 to about 18 carbon atoms, esters of sugars and aliphatic acids containing from about 10 to about 18 carbon atoms; sugar acids, saponins; and sapogenins; and (e) a member selected from the group consisting of glycerol, glycerol di or triesters of aliphatic acids containing from about 10 to about 18 carbon atoms and aliphatic alcohols containing from about 10 to about 18 carbon atoms; D. shaking said solution mechanically for from about 2 to about 10 seconds in gaseous atmosphere at room temperature, thereby forming a concentrated gas-in-liquid emulsion; and E. passing the solution obtained after step (D) through a sterile polysulfone membrane filter having an average pore diameter of about 0.40-6.0 μm.
Claim 2
Independent Claim
292 words
A method for preparing an imaging about suitable for enhancement of ultrasonic imaging and magnetic resonance imaging comprising the steps of: A. obtaining a moderately hydrophobic neutral amino acid homopolymer or copolymer which is capable of readily incorporating into a lipid monolayer, and is labeled with a paramagnetic complex comprising a metal ion and organic chelating ligand; B. dissolving the labeled, hydrophobic polymer in a saline solution in an amount of about 10 mM; C. adding a surfactant mixture comprising: (a) a member selected from the group consisting of glycerol monoesters of saturated carboxylic acids containing from about 10 to about 18 carbon atoms and aliphatic alcohols containing from about 10 to about 18 carbon atoms; (b) a sterol-aromatic acid ester; (c) a member selected from the group consisting of sterols, terpenes, bile acids and alkali metal salts of bile acids; (d) a member selected from the group consisting of sterol esters of aliphatic acids containing from one to about 18 carbon atoms; sterol esters of sugar acids; esters of sugar acids and aliphatic alcohols containing from about 10 to about 18 carbon atoms, esters of sugars and aliphatic acids containing from about 10 to about 18 carbon atoms; sugar acids, saponins; and sapogenins; and (e) a member selected from the group consisting of glycerol, glycerol di or triesters of aliphatic acids containing from about 10 to about 18 carbon atoms and aliphatic alcohols containing from about 10 to about 18 carbon atoms; D. shaking said solution mechanically for from about 2 to about 10 seconds in gaseous atmosphere at room temperature, thereby forming a concentrated gas-in-liquid emulsion; and E. passing the solution obtained after step (D) through a sterile polysulfone membrane filter having an average pore diameter of about 0.40-6.0 μm.
Claim 3
Dependent Claim
34 words
A method according to claim 1, further comprising the steps of allowing undissolved lipid materials to settle out for a period of about 15-60 minutes before passing the solution through the polysulfone membrane filter.
Claim 4
Dependent Claim
21 words
A method according to claim 2, wherein the sterile polysulfone membrane filter has an average pore diameter of about 0.40-0.60 μm.
Claim 5
Dependent Claim
21 words
A method according to claim 3, wherein the sterile polysulfone membrane filter has an average pore diameter of about 45 μm.
Claim 6
Dependent Claim
27 words
A method according to claim 3, wherein the moderately hydrophobic polymer is selected from the group consisting of homopolymers of valine, glycine and alanine and copolymers thereof.
Claim 7
Dependent Claim
26 words
A method according to claim 5, wherein the paramagnetic complex is selected from the group consisting of gadolinium DTPA, manganese DTPA, gadolinium EDTA and manganese EDTA.
Claim 8
Dependent Claim
13 words
A method according to claim 6 wherein the paramagnetic complex is gadolinium DTPA.
Claim 9
Dependent Claim
25 words
A method according to claim 7, wherein the surfactant mixture components are present in the surfactant mixture in a weight ratio a:b:c:d:e of about 2-4:0.5-1.5:0.5-1.5:0.5-1.5:0-1.5.
Claim 10
Dependent Claim
29 words
A method according to claim 8, wherein the surfactant mixture consists essentially of glycerol monolaurate, cholesterol benzoate, cholesterol, cholesterol acetate and glycerol tripalmitate in a weight ratio of 2-4:1:1:1:1.
Claim 11
Dependent Claim
29 words
A method according to claim 1, further comprising the steps of mechanically shaking the solution at least two more times before passing the solution through the polysulfone membrane filter.
References Cited (Backward Citations)
US4276885A
Cited
US4466442A
Cited
US4572203A
Cited
US4900540A
Cited
US4985233A
Cited
US4684479A
Cited
US4832941A
Cited
US4774958A
Cited
US4927637A
Cited
US5078986A
Cited
US5088499A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1996-05-31 | 1996-11-30 | 1997-06-01 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2000-05-31 | 2000-11-30 | 2001-06-01 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2004-05-31 | 2004-11-30 | 2005-06-01 | $7700.00 | Window Closed / Lapsed |